How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?: Insights generated from a multi-stakeholder survey in hematology/oncology

OBJECTIVES: We conducted a multi-stakeholder survey to determine key areas where a joint European health technology assessment (HTA) could provide ‘additional benefit’ compared to the status quo of many parallel independent national and subnational assessments. METHODS: Leveraging three iterative De...

Descripción completa

Detalles Bibliográficos
Autores principales: Julian, Elaine, Gianfrate, Fabrizio, Sola-Morales, Oriol, Mol, Peter, Bergmann, Jean-François, Salmonson, Tomas, Hebborn, Ansgar, Grande, Mathilde, Ruof, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161501/
https://www.ncbi.nlm.nih.gov/pubmed/35652987
http://dx.doi.org/10.1186/s13561-022-00379-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161501/
https://www.ncbi.nlm.nih.gov/pubmed/35652987
http://dx.doi.org/10.1186/s13561-022-00379-7

Ejemplares similares